PathAI

Overview

PathAI is a company based in the United States that specializes in the application of artificial intelligence within the fields of digital pathology and oncology. Founded in 2016, the company operates within the Business Services industry, particularly focusing on research and development, computer software, and clinical laboratory services. PathAI's expertise is evident in its published research, which includes studies on the use of AI for quantifying nuclear morphology in cancer, assessing immune microenvironments, and evaluating the efficacy of immunotherapy in non-small cell lung cancer. Their work emphasizes the integration of machine learning techniques to enhance diagnostic accuracy and predict patient outcomes, as seen in various manuscripts that explore the correlation between AI-driven assessments and traditional manual methods. PathAI engages in advancing cancer research through innovative methodologies, contributing to the understanding of cancer biology and treatment responses. The company employs between 501 and 1,000 individuals and reported revenue of approximately $106.7 million.

Industry